Dene Firth pictured with family members

17 Oct 2023

“It was a terrible experience and we miss him every day”

Forty-seven-year-old Dene Firth was working as a property clerk in South Yorkshire Police in 2019 when he began to have bad night sweats and was also feeling very tired. He then developed a painful, swollen foot, for which he decided to seek the help of a physiotherapist.   

“The physiotherapist realised immediately this wasn’t a problem that she could do something about and sent him to his GP,” said Dene’s wife Diane, 55, who lives in Barnsley and works as general assistant at Tesco.  “The GP gave Dene a blood test on 4th September 2019, and by that afternoon he was in Sheffield’s Hallamshire Teaching Hospital with a diagnosis of acute myeloid leukaemia (AML)  

“Dene was quite healthy – he was a football coach for his son’s team. Getting the diagnosis was a terrible shock. As well as the disbelief it was also very frightening. But despite our fear of the future, we remained hopeful it could be cured.”  

Dene immediately started chemotherapy which was extremely gruelling. He lost his appetite and slept for long periods of time. The treatment was also hard on Diane and the couple’s two children Megan, 17, and Alfie, 14.  

“It was unbearable at times,” said Diane. “I went to the hospital every day and was also trying to look after our two children. Megan was very caring, looking after her Dad, and asking questions about what was going to happen. But Alfie went quiet. I did manage to go to the gym and it helped me cope.” 

Dene was given two gruelling rounds of chemotherapy. He was then lined up for a stem cell transplant and a donor was found, although everything was delayed as by that time the Covid pandemic and lockdown had started. But, in order for the transplant to take place, Dene needed to have below 5% cancerous cells in his body. Tragically he still had over 40% by the end of his second round of chemotherapy.   

Dene was offered a third round of chemotherapy, with very low chances of success, or palliative care using a new trial drug. Dene opted for palliative care so he could spend more quality time with his family. Dene sadly passed away on 9th July 2020 at the age of 48. 

“It was a terrible experience and we miss him every day,” said Diane. “But I try to I take every day as it comes and make memories with my family.” 

Read more stories from people affected by leukaemia.

Related posts

£200 grants for people affected by leukaemia once again available

4 April 2023

£200 grants for people affected by leukaemia once again available

Leukaemia UK and Leukaemia Care have this month relaunched the ‘Cost of Living Fund’, providing financial grants of £200 to patients with leukaemia, myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs),…

Leukaemia UK appoints Ian McCafferty CBE as their new Chair of Trustees to support new strategy to stop leukaemia devastating lives

7 November 2022

Leukaemia UK appoints Ian McCafferty CBE as their new Chair of Trustees to support new strategy to stop leukaemia devastating lives

Ian McCafferty CBE will take up the role in January 2023, from current Chair of Trustees, Chris Corbin OBE, and will lead the charity as it continues to grow. Chris…

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

20 October 2023

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…

Why I became a Leukaemia UK Trustee

11 February 2021

Why I became a Leukaemia UK Trustee

Caroline Evans – Leukaemia UK Trustee and Projects Consultant – reflects on why she became a Trustee and what drives her in the role.